Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space.
Saved in:
| Title: | Finerenone Prescriptions in the United States (2021-2024) by Physician Specialty: Analysis of Use and Potential in the Cardiovascular-Kidney-Metabolic Space. |
|---|---|
| Authors: | Jelwan Y; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Cao T; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA.; Johns Hopkins Bloomberg School of Public Health Baltimore MD USA., Yao Z; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Burka S; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Erhabor J; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Berning P; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA., Dzaye O; University of Texas Southwestern Medical Center Dallas TX USA., Blaha M; Johns Hopkins Ciccarone Center for Cardiovascular Disease Prevention Baltimore MD USA. |
| Source: | Journal of the American Heart Association [J Am Heart Assoc] 2026 Jun 16; Vol. 15 (12), pp. e046837. Date of Electronic Publication: 2026 Jun 09. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 101580524 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2047-9980 (Electronic) Linking ISSN: 20479980 NLM ISO Abbreviation: J Am Heart Assoc Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
